Francis Farraye to Clinical Trials, Phase III as Topic
This is a "connection" page, showing publications Francis Farraye has written about Clinical Trials, Phase III as Topic.
Connection Strength
0.043
-
COVID-19 vaccine use in immunocompromised patients: A commentary on evidence and recommendations. Am J Health Syst Pharm. 2022 01 05; 79(2):63-71.
Score: 0.043